Abstract:Objective To explore the relationship between C-peptide and glycaemic control rate and diabetic complications (microvascular complication and cerebral infarction) and provide evidence for stratified treatment of type 2 diabetes mellitus (T2DM)-based C-peptide. Method This is a cross-sectional real-world observational study. According to the inclusion and exclusion criteria, we studied 1377 patients with T2DM, grouped by fasting C-peptide and HOMA-IR. Blood samples were collected after fasting overnight. Logistic regression was used to analyse the relationship among fasting C-peptide, HOMA-IR, C2/C0 ratio (the ratio of 2 h postprandial C-peptide to fasting C-peptide), glycaemic control rate, and occurrence of diabetic complications. Restricted cubic spline (RCS) curves based on logistic regression were used to evaluate the relationship between C-peptide, glycaemic control rate, and diabetic kidney disease (DKD). Results Patients were subdivided according to their fasting C-peptide in 4 groups (Q1,Q2,Q3,Q4). Patients of group Q3 (1.71 <= C-peptide < 2.51 ng/ml) showed the lowest incidence of DKD, diabetic retinopathy (DR), and rate of insulin absorption as welll as higher glycaemic control rate. Logistic regression shows that the probability of reaching glycemic control increased with higher levels of C-peptide, compared with group Q1, after adjusting for age, gender, duration of diabetes, body mass index, systolic blood pressure, diastolic blood pressure, creatinine, low-density lipoprotein, triglyceride, total cholesterol, and high-density lipoprotein. RCS curve shows that, when C-peptide is <= 2.68 ng/ml, the incidence of not reaching glycaemic control decreases with increasing C-peptide. The possibility of not reaching glycaemic control decreased with increasing C2/C0, when C-peptide is >= 1.71 ng/ml. RCS curve shows that the relationship between C-peptide and DKD follows a U-style curve. When C-peptide is <2.84 ng/ml, the incidence of DKD decreased with increasing C-peptide. With the increase in the C2/C0 ratio, the incidence of DKD, DR, and fatty liver did not decrease. Conclusion When C-peptide is >= 1.71 and < 2.51 ng/ml, patients with T2DM had a higher glycemic control rate. Excessive C-peptide plays different roles in DKD and DR; C-peptide may promote the incidence of DKD but protects patients from DR. Higher C2/C0 ratio is important for reaching glycaemic control but cannot reduce the risk of DKD, DR, and fatty liver.

Serum C-peptide as a key contributor to lipid-related residual cardiovascular risk in the elderly.

Association Between Serum C-Peptide As A Risk Factor For Cardiovascular Disease And High-Density Lipoprotein Cholesterol Levels In Nondiabetic Individuals

Association between physical activity and serum C-peptide levels among the elderly.

Independent association between serum C-peptide levels and fat mass-to-lean mass ratio in the aging process.

Associations of Serum C-Peptide Level with Body Fat Distribution and Ever Stroke in Nondiabetic Subjects

IGFBP7 and GDF-15, but not P1NP, are associated with cardiac alterations and 10-year outcome in an elderly community-based study

[Plasma Gamma-Glutamyl Transpeptidase Level As a Cardiovascular Risk Factor in Elderly Patients with Hypertension or Hypertension with Diabetes Mellitus].

Association of C-peptide with Diabetic Vascular Complications in Type 2 Diabetes.

The Association Between The Serum C-Peptide Level And Bone Mineral Density

High levels of serum C-peptide are associated with a decreased risk for incident renal progression in patients with type 2 diabetes: a retrospective cohort study

Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)

Effects of Serum C-Peptide Level on Blood Lipid and Cardiovascular and Cerebrovascular Injury in Patients with Type 2 Diabetes Mellitus: A Meta-Analysis

Serum CTRP1 level and its relationship with serum adiponectin level in elderly male metabolic syndrome patients

Associations of serum C-peptide and insulin-like growth factor binding proteins-3 with breast cancer deaths

Serum C‐reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice

453-P: Serum Lipocalcin-2 Levels, Fat Distribution, and the Risk of Cardiovascular Events—A Chinese Community-Based Longitudinal Cohort

Serum C Reactive Protein and Procalcitonin Are Valuable Predictors of Coronary Heart Disease and Poor Prognosis in the Elderly.

Serum Pentosidine is Associated with Cardiac Dysfunction and Atherosclerosis in T2DM

Elevated Serum Chemokine CXC Ligand 5 Levels Are Associated with Hypercholesterolemia but Not a Worsening of Insulin Resistance in Chinese People.

C-peptide, Glycaemic Control, and Diabetic Complications in Type 2 Diabetes Mellitus: A Real-World Study.

Serum Resistin and Adiponectin Concentrations in Patients with Overweight and Obesity